Skip to main content

FDA accepts approval application from Warner Chilcott


ARDEE, Ireland The Food and Drug Administration has accepted an approval application for a low-dose oral contraceptive from Warner Chilcott, the drug maker announced Wednesday.

The agency accepted Warner Chilcott’s new drug application for WC 3016, submitted through a subsidiary on March 26.

The company recently relocated its headquarters from Bermuda to Ireland.

This ad will auto-close in 10 seconds